Preventing Young Infant Infections Using Azithromycin in Labour (PreYIAL) Trial
Status:
Recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
A trial to assess cumulative incidence of skin and soft tissue infections (SSTI) in infants
(by three months of age) born to mothers receiving a single-dose of 2 grams of oral
azithromycin during labour (or immediately prior to delivery in the case of caesarean
section), compared to infants whose mothers received placebo.